第39回日本分子生物学会シンポジウム [3AS13]（2016.12.2 横浜）
NOVEL STRATEGIES TOWARD UNDERSTANDING MECHANISMS THAT LEAD TO REFRACTORY CANCER
Organizers:
Satoshi Inoue (Saitama Med Univ/Tokyo Metro Inst of Gerontol)
Koji Okamoto (Natl Cancer Ctr Res Inst)
[3AS13-1]
Identification of stemness-maintaining factors in breast cancer stem cells
Takahiko Maruyama (IMS, Univ of Tokyo)
[3AS13-2]
In vitro cultivation and characterization of cancer stem cells derived from refractory cancer in spheroid culture
Koji Okamoto (Natl Cancer Ctr Res Inst)
[3AS13-3]
Identification of targets of tumor suppressor microRNA-341 using a reporter library system
Yoshiaki Ito (Dept Syst BioMed,Tokyo Med Dent Univ)
[3AS13-4]
Co-factor and epigenomic control of hormone sensitive and refractory human cancers
Debabrata Chakravarti (Northwestern Univ, Chicago,USA)
[3AS13-5]
Functional shRNA library screening and sequencing-based identification of coding and non-coding RNAs that associate with the biology of hormone refractory cancers
Kuniko Horie (Res Ctr for Genomic Med, Saitama Med Univ)
[3AS13-6]
Toward tailoring colorectal cancer chemotherapeutics via patient derived organoids
Masayuki Fujii (Dept of Int Med, Dev of Gastrorenterol, Keio Univ Sch of Med)
[3AS13-7]
Reconstructing tumor microenvironment in cancer organoids
Ryo Okuda (Dept of Regenerative Med, Yokohama City Univ, Grad Sch Med)
[3AS13-8]
Dependence on the mitochondrial MTHFD2-mediated purine synthetic pathway in lung cancer
Noriko Gotoh (Div of Cancer Cell Biol, Cancer Res Inst, Kanazawa Univ)
